Evidence map›Paper›PMID 35265752›Full record

ReviewHeliyon2022

Systematic review and meta-analysis of environmental

H Onohuean, E Agwu, U U Nwodo

Open access · goldAbstract readReview
In one paragraph

Review in Heliyon, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 3 pooled it
8.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 3 syntheses or guidelines pooled it, 41 citations in OpenAlex.

  1. ManagingMolecules (Basel, Switzerland) · 2025
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Resistance ofFrontiers in pharmacology · 2023
    Review
  12. Antimicrobial resistance genes ofAIMS microbiology · 2023
    Review
  13. Article
  14. Review
  15. Article
  16. Insights into theAntibiotics (Basel, Switzerland) · 2022
    Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

H OnohueanBiopharmaceutics Unit, Department of Pharmacology and Toxicology, School of Pharmacy, Kampala International University Western Campus, Ishaka, Bushenyi, Uganda.
E AgwuDepartment of Microbiology and Immunology, Kampala International University, Western Campus, Ishaka, Bushenyi, Kampala, Uganda.
U U NwodoSA-MRC Microbial Water Quality Monitoring Centre, University of Fort Hare, Alice 5700, South Africa.
University of Fort Hare · ZAKampala International University · UG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adequate comprehension of the genomics of microbial resistance to an antimicrobial agent will advance knowledge on the management of associated pathologies and public health safety. However, continued emergences and reemergence of pathogens, including

Indexed as

Antibiotics resistance genesEnvironmentalIncidentsIsolatesPrevalenceVibrio species

Identifiers

PMID35265752
PMCPMC8899705
OpenAlexW4210331812

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.